SRNE Stock – Health Care Sector Update for 03/09/2021: SRNE,INVO,ANPC,OGEN
Health care stocks eased modestly from earlier highs during afternoon trading, with the NYSE Health Care Index rising 1.2% while the SPDR Health Care Select Sector ETF was up 1.1%.
The Nasdaq Biotechnology index climbed 3.5%.
In company news, Sorrento Therapeutics (SRNE) added more than 12% after signing an exclusive licensing deal for COVID-19 antibodies developed by the Icahn School of Medicine at Mount Sinai in New York. Financial terms were not disclosed.
Invo Bioscience (INVO) was up more than 215% after announcing an expanded commercialization deal with privately held Ferring Pharmaceuticals increasing the number of Invo-owned clinics and garnering a $501,000 order from Ferring for the company’s infertility treatment products.
Oragenics (OGEN) jumped nearly 46% after announcing a material transfer agreement with privately held Biodextris for the use of three intranasal mucosal adjuvants increasing the immunogenicity of its Terra CoV-2 vaccine candidate for COVID-19.
AnPac Bio-Medical Science (ANPC) rose almost 40% after the diagnostics company said it developed an improved line of multi-cancer detection equipment that will reduce costs by 137% compared with its previous line, while demonstrating a specificity of more than more than 95%, with the new CDA Pro Sensors capable of measuring subtle changes in biophysical properties of a blood sample.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.